Development of a Luminex-based multiplex assay for detection of mutations conferring resistance to Echinocandins in Candida glabrata

Journal of Clinical Microbiology
Cau D PhamS R Lockhart

Abstract

Echinocandins are the recommended treatment for invasive candidiasis due to Candida glabrata. Resistance to echinocandins is known to be caused by nonsynonymous mutations in the hot spot-1 (HS1) regions of the FKS1 and FKS2 genes, which encode a subunit of the β-1,3-glucan synthase, the target of echinocandins. Here, we describe the development of a microsphere-based assay using Luminex MagPix technology to identify mutations in the FKS1 HS1 and FKS2 HS1 domains, which confer in vitro echinocandin resistance in C. glabrata isolates. The assay is rapid and can be performed with high throughput. The assay was validated using 102 isolates that had FKS1 HS1 and FKS2 HS1 domains previously characterized by DNA sequencing. The assay was 100% concordant with DNA sequencing results. The assay was then used for high-throughput screening of 1,032 C. glabrata surveillance isolates. Sixteen new isolates with mutations, including a mutation that was new to our collection (del659F), were identified. This assay provides a rapid and cost-effective way to screen C. glabrata isolates for echinocandin resistance.

References

Apr 2, 2008·Antimicrobial Agents and Chemotherapy·John D ClearyDavid S Perlin
Feb 5, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Peter G PappasUNKNOWN Infectious Diseases Society of America
Feb 25, 2009·Archives of Internal Medicine·Ingi LeeEbbing Lautenbach
Feb 27, 2009·Journal of Clinical Microbiology·Kizee A EtienneS Arunmozhi Balajee
Feb 11, 2010·Antimicrobial Agents and Chemotherapy·Guillermo Garcia-EffronHector Bonilla
Apr 28, 2010·Journal of Clinical Microbiology·Christopher D PfeifferBarbara D Alexander
Sep 15, 2010·Antimicrobial Agents and Chemotherapy·Alicia J ZimbeckShawn R Lockhart
Sep 2, 2011·Journal of Clinical Microbiology·N Esther BabadyKathleen A Gilhuley
Dec 16, 2011·Journal of Clinical Microbiology·Joan-Miquel Balada-LlasatPreeti Pancholi
Aug 16, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Angela Ahlquist ClevelandTom M Chiller
Mar 15, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Barbara D AlexanderMichael A Pfaller

❮ Previous
Next ❯

Citations

Aug 6, 2014·Intensive Care Medicine·Danièle MaubonMuriel Cornet
Jan 8, 2016·Infectious Disease Clinics of North America·Mohammad T AlbatainehNathan P Wiederhold
Feb 7, 2015·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·D Farmakiotis, D P Kontoyiannis
Apr 6, 2017·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M Sanguinetti, B Posteraro
Feb 9, 2017·Frontiers in Microbiology·Liliana ScorzoniAna M Fusco-Almeida
Mar 6, 2018·The Journal of Antimicrobial Chemotherapy·Todd P McCartyPeter G Pappas
Aug 24, 2016·Antimicrobial Agents and Chemotherapy·Yanan ZhaoDavid S Perlin
May 16, 2014·Journal of Clinical Microbiology·Catiana DudiukGuillermo Garcia-Effron
Jul 24, 2015·Journal of Clinical Microbiology·Cau D PhamShawn R Lockhart
Nov 3, 2017·Current Opinion in Infectious Diseases·Arnaldo L ColomboJesus Guinea
Sep 16, 2017·The Journal of Infectious Diseases·David S Perlin, Nathan P Wiederhold
Oct 12, 2014·Current Opinion in Infectious Diseases·Maiken C Arendrup, David S Perlin
Nov 3, 2015·Current Opinion in Infectious Diseases·Ryan K ShieldsCornelius J Clancy
May 1, 2020·Clinical Microbiology Reviews·Elizabeth L BerkowLuis Ostrosky-Zeichner
Sep 6, 2020·Antibiotics·María Guadalupe Frías-De-LeónErick Martínez-Herrera
Feb 15, 2021·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Hazim O KhalifaKatsuhiko Kamei
Jun 4, 2019·FEMS Microbiology Reviews·UNKNOWN Consortium OPATHY, Toni Gabaldón
Oct 12, 2016·Microbiology Spectrum·Sean X Zhang, Nathan P Wiederhold
Jun 29, 2021·Current Fungal Infection Reports·P Lewis WhiteMatthijs Backx
Aug 12, 2021·JAC-antimicrobial Resistance·Alexander Maximilian AldejohannOliver Kurzai

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.